The Canadian province of Alberta has registered the second death in the country due to a blood clotting disorder after the AstraZeneca vaccination against the coronavirus, said the chief health officer of the province, Dina Hinshaw.
Earlier it was reported that the first case of death after vaccination with the AstraZeneca vaccine in Canada was registered in the province of Quebec at the end of April.
“As Chief Health Officer, I am saddened to announce that tonight (May 4) we have confirmed the death of an Alberta woman in her 50s from thrombosis following an AstraZeneca vaccination,” Hinshaw said in a press release on the provincial health service’s website.
According to the chief physician of Alberta, out of respect for medical confidentiality and the confidentiality of the family of the deceased, the authorities will not provide further information about the case.
At the same time, Hinshaw recalled that the risk of death or complications from the coronavirus exceeds the risks from vaccination.
“For comparison, the probability of death among COVID-19 patients in Alberta aged 50 to 59 years is 350 times more likely to form a thrombosis after the AstraZeneca vaccine. The probability that they will be hospitalized due to COVID-19 is at least 1,500 times greater than the probability of forming a thrombosis after the AstraZeneca vaccine,” said the chief physician of Alberta. Health Canada approved the use of the AstraZeneca coronavirus vaccine on February 26. In addition, Pfizer/BioNTech, Moderna, and Janssen are authorized in the country.